Related Articles by Review for PMID: 23940778

Year	Number of Results
2008	1
2012	2
2013	3
2014	1
2018	2
2020	3
2021	1
2023	1
2024	0

1

Proteomic analysis of signaling network regulation in renal cell carcinomas with differential hypoxia-inducible factor-2α expression.

Nagaprashantha LD, Talamantes T, Singhal J, Guo J, Vatsyayan R, Rauniyar N, Awasthi S, Singhal SS, Prokai L. Nagaprashantha LD, et al. PLoS One. 2013 Aug 5;8(8):e71654. doi: 10.1371/journal.pone.0071654. Print 2013. PLoS One. 2013. PMID: 23940778 Free PMC article.

2

Metabolism of kidney cancer: from the lab to clinical practice.

Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM. Sudarshan S, et al. Eur Urol. 2013 Feb;63(2):244-51. doi: 10.1016/j.eururo.2012.09.054. Epub 2012 Sep 28. Eur Urol. 2013. PMID: 23063455 Free PMC article. Review.

3

The VHL tumor suppressor and HIF: insights from genetic studies in mice.

Kapitsinou PP, Haase VH. Kapitsinou PP, et al. Cell Death Differ. 2008 Apr;15(4):650-9. doi: 10.1038/sj.cdd.4402313. Epub 2008 Jan 25. Cell Death Differ. 2008. PMID: 18219317 Free PMC article. Review.

4

Significance of PI3K signalling pathway in clear cell renal cell carcinoma in relation to VHL and HIF status.

Tumkur Sitaram R, Landström M, Roos G, Ljungberg B. Tumkur Sitaram R, et al. J Clin Pathol. 2021 Apr;74(4):216-222. doi: 10.1136/jclinpath-2020-206693. Epub 2020 May 28. J Clin Pathol. 2021. PMID: 32467322 Review.

5

Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma.

Bacigalupa ZA, Rathmell WK. Bacigalupa ZA, et al. Cancer Lett. 2020 Oct 1;489:19-28. doi: 10.1016/j.canlet.2020.05.034. Epub 2020 Jun 5. Cancer Lett. 2020. PMID: 32512023 Free PMC article. Review.

6

Lipids as Targets for Renal Cell Carcinoma Therapy.

Stepanovska Tanturovska B, Manaila R, Fabbro D, Huwiler A. Stepanovska Tanturovska B, et al. Int J Mol Sci. 2023 Feb 7;24(4):3272. doi: 10.3390/ijms24043272. Int J Mol Sci. 2023. PMID: 36834678 Free PMC article. Review.

7

Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer.

Meléndez-Rodríguez F, Roche O, Sanchez-Prieto R, Aragones J. Meléndez-Rodríguez F, et al. Front Oncol. 2018 Jun 8;8:214. doi: 10.3389/fonc.2018.00214. eCollection 2018. Front Oncol. 2018. PMID: 29938199 Free PMC article. Review.

8

Hypoxia-inducible factor 2α: a novel target in gliomas.

Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE. Renfrow JJ, et al. Future Med Chem. 2018 Sep 1;10(18):2227-2236. doi: 10.4155/fmc-2018-0163. Epub 2018 Aug 9. Future Med Chem. 2018. PMID: 30089425 Free PMC article. Review.

9

Renal cancer: oxygen meets metabolism.

Haase VH. Haase VH. Exp Cell Res. 2012 May 15;318(9):1057-67. doi: 10.1016/j.yexcr.2012.02.026. Epub 2012 Mar 3. Exp Cell Res. 2012. PMID: 22406000 Free PMC article. Review.

10

Targeting the HIF2-VEGF axis in renal cell carcinoma.

Choueiri TK, Kaelin WG Jr. Choueiri TK, et al. Nat Med. 2020 Oct;26(10):1519-1530. doi: 10.1038/s41591-020-1093-z. Epub 2020 Oct 5. Nat Med. 2020. PMID: 33020645 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year